This FTSE 100 blue-chip could rise 26% in 12 months, according to brokers
To achieve a 26% return on any individual FTSE stock in a year would be a great outcome. Assuming the share was a fairly decent-sized holding, that gain could help power a market-beating portfolio performance. Diageo (LSE: DGE) could be one such stock, according to most analysts. Going on their consensus price target of 2,410p, […]
Oral Semaglutide: Will Injectors Switch?
Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some fear misuse of oral agents. Medscape Medical News
A Dose Of Disruption: How Compounding Pharmacies Are Challenging Big Pharma On GLP-1 Drugs And Drug Patents
As demand for GLP-1 drugs grows, compounding pharmacies and telehealth startups are challenging Big Pharma’s grip on pricing, patents, and access to care.
Plus-size clothes are disappearing in the Ozempic era
Getty Images; Rebecca Zisser/BI Tess Holliday remembers 2019 as a “glorious” year for plus-size fashion and body positivity. The plus-size model and body activist walked the runway at New York Fashion Week. She’d been featured by magazines such as Cosmopolitan UK, Nylon, and Self. The cultural shift felt palpable — Rihanna’s Savage X Fenty runway […]
I shrunk from 25.5st to 15st with fat jabs – there’s a side effect that was agony but a £1.60 buy fixed it
A MUM-OF-TWO who shed almost half her bodyweight using fat jabs has shared the one piece of advice she wish she knew before kickstarting her health journey. Camilla Do Rosario, who topped the scales at 25.5 stone at her heaviest, was reflecting on what she would advise herself before discovering Mounjaro in April 2024. tiktok/@camilla.and.familyThe mum-of-two kickstarted […]
I stopped taking Mounjaro for 2 weeks & here’s what really happens – yes, I’ve gained weight and I was ‘uncontrollable’
AFTER ditching Mounjaro for two weeks to go on holiday, a mother has shared what really happens when you stop taking fat jabs. Carmel Elizabeth Smith, a mother from the UK, weighed 16 stone before she started using the injections in a bid to slim down. TikTok/mounjarojourneyandme2A mother has revealed what really happens when you […]
Walmart: Upcoming SNAP Cuts, GLP-1, And Other Headwinds Make The Valuation Unpalatable
Tirzepatide tops the charts for blood sugar and weight loss in type 2 diabetes
A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with type 2 diabetes. Tirzepatide demonstrated the greatest efficacy for glucose control and weight loss, while liraglutide offered the lowest hypoglycemia risk.
Officials Investigate Potentially Deadly Side Effect of Weight-Loss Drugs
Health officials in the UK are launching an investigation into weight loss drugs after hundreds of consumers reported pancreas issues. Many cases of pancreatitis are linked to GLP-1, glucagon-like peptide-1 receptor agonists — and many of those cases have been fatal. Nearly 400 reports of pancreatitis are from patients using Mounjaro, Wegovy, Ozempic and liraglutide. A quarter […]
Tirzepatide Outperforms Semaglutide in Head-to-Head Obesity Trial
The glucagon-like peptide 1 receptor agonists semaglutide and tirzepatide have both shown efficacy for obesity management. In clinical trials for the individual drugs, tirzepatide—which is also a glucose-dependent insulinotropic polypeptide receptor agonist—resulted in more weight loss on average than semaglutide did. A new head-to-head trial directly comparing the medications appears to confirm these findings.